Kuwait Oligonucleotide Synthesis Market Size & Outlook

The oligonucleotide synthesis market in Kuwait is expected to reach a projected revenue of US$ 11.6 million by 2033. A compound annual growth rate of 10.6% is expected of Kuwait oligonucleotide synthesis market from 2026 to 2033.
Revenue, 2025 (US$M)
$5.3
Forecast, 2033 (US$M)
$11.6
CAGR, 2026 - 2033
10.6%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait oligonucleotide synthesis market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait oligonucleotide synthesis market highlights

  • The Kuwait oligonucleotide synthesis market generated a revenue of USD 5.3 million in 2025 and is expected to reach USD 11.6 million by 2033.
  • The Kuwait market is expected to grow at a CAGR of 10.6% from 2026 to 2033.
  • In terms of segment, services was the largest revenue generating product in 2025.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Oligonucleotide synthesis market data book summary

Market revenue in 2025USD 5.3 million
Market revenue in 2033USD 11.6 million
Growth rate10.6% (CAGR from 2026 to 2033)
Largest segmentServices
Fastest growing segmentServices
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationOligonucleotides, Equipment/Synthesizer, Reagents, Services
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.1% of the global oligonucleotide synthesis market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 56.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oligonucleotide Synthesis Market Companies

Name Profile # Employees HQ Website
Biolegio View profile 11-50 Nijmegen, Gelderland, The Netherlands, Europe http://www.biolegio.com
Bio-Synthesis View profile 11-50 Seminole, Texas, United States, North America http://www.biosyn.com
Twist Bioscience Corp View profile 919 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 https://www.twistbioscience.com
Heritage Global Inc View profile 82 12625 High Bluff Drive, Suite 305, San Diego, CA, United States, 92130 https://www.hginc.com
Kaneka Corp View profile 13284 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 http://www.kaneka.co.jp
Agilent Technologies View profile 10001+ Santa Clara, California, United States, North America http://www.agilent.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Kuwait oligonucleotide synthesis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.


Services was the largest segment with a revenue share of 41.51% in 2025. Horizon Databook has segmented the Kuwait oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.


The growing prevalence of genetic disorders is expected to increase the demand for effective treatments, driving the oligonucleotide synthesis market growth in Kuwait. Oligonucleotide-based therapies have shown assurance in treating numerous genetic disorders, including those that were previously considered untreatable, such as spinal muscular atrophy.

As a result, there has been a significant increase in R&D activities to develop oligonucleotide-based therapies for genetic disorders. In addition, the rising incidence of cancer and viral infections has contributed to the oligonucleotide synthesis market growth. According to WHO, in 2020, approximately 3,842 cancer cases were registered in Kuwait.

Reasons to subscribe to Kuwait oligonucleotide synthesis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait oligonucleotide synthesis market databook

  • Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait oligonucleotide synthesis market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait oligonucleotide synthesis market size, by product, 2021-2033 (US$M)

Kuwait Oligonucleotide Synthesis Market Outlook Share, 2025 & 2033 (US$M)

Kuwait oligonucleotide synthesis market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online